麻豆中文字幕丨欧美一级免费在线观看丨国产成人无码av在线播放无广告丨国产第一毛片丨国产视频观看丨七妺福利精品导航大全丨国产亚洲精品自在久久vr丨国产成人在线看丨国产超碰人人模人人爽人人喊丨欧美色图激情小说丨欧美中文字幕在线播放丨老少交欧美另类丨色香蕉在线丨美女大黄网站丨蜜臀av性久久久久蜜臀aⅴ麻豆丨欧美亚洲国产精品久久蜜芽直播丨久久99日韩国产精品久久99丨亚洲黄色免费看丨极品少妇xxx丨国产美女极度色诱视频www

Insulin study points to better diabetes treatment: researchers

Source: Xinhua| 2018-10-24 17:16:31|Editor: xuxin
Video PlayerClose

SYDNEY, Oct. 24 (Xinhua) -- Australian researchers on Wednesday said they have helped shed new light on role of insulin in reducing blood sugar levels in the body, pointing to better treatment of diabetes.

The international study, co-led by researchers at Australia's Walter and Eliza Hall Institute, revealed the first definitive 3D image of how insulin successfully interacts with its receptor, a "gatekeeper" for transmitting information into cells, in a process that is crucial for instructing cells to lower blood sugar levels in the body, the medical facility said in a statement.

Understanding exactly what the process looks like could help the development of faster-acting and longer-lasting insulin therapies for the major disease, it said.

"Current insulin therapies are sub-optimal because they have been designed without this missing piece of the puzzle," said the institute's associate professor Mike Lawrence.

"We knew that insulin underwent a physical change that signalled its successful connection with its receptor on the cell surface. But we had never before seen the detailed changes that occurred in the receptor itself, confirming that insulin had successfully delivered the message for the cell to take up sugar from the blood," he added.

The findings were published in scientific journal Nature Communications.

Diabetes is a complex medical condition that includes difficulty in maintaining healthy glucose levels in the blood.

People with diabetes no longer produce, or are unable to produce sufficient amounts of insulin which is essential for the conversion of glucose into energy.

Nearly 300 Australians develop diabetes every day, or one person every five minutes, according to the Diabetes Australia nonprofit health group.

"Going forward, pharmaceutical companies will be able to use our data as a 'blueprint' for designing therapies that optimize the body's uptake of insulin," said Lawrence.

"It is phenomenal to have achieved results that will ultimately benefit patients with the development of more effective therapies, particularly for those whose lives are dependent on a daily injection of insulin," he added.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011100001375551901